4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-001600
Chief Financial Officer gave up 10,553 shares (to pay taxes)
- Chief Financial Officer acquired 18,850 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bellemin Jean-Marc · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-03 | Exercise or conversion : show line 1 in the form | +18,850 | 28,354 | D | ||
| 2023-01-03 | Shares withheld for taxes : show line 2 in the form | −10,553 | $6.11 | $64,479 | 17,801 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-03 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −18,850 | 0 | D |
Loading xslF345X03/tm232380d1_4seq1.xml…